Th17-inducing autologous dendritic cell vaccination promotes antigen-specific cellular and humoral immunity in ovarian cancer patients

Block, M. S., Dietz, A. B., Gustafson, M. P., Kalli, K. R., Erskine, C. L., Youssef, B., Vijay, G. V., Allred, J. B., Pavelko, K. D., Strausbauch, M. A., Lin, Y., Grudem, M. E., Jatoi, A., Klampe, C. M., Wahner-Hendrickson, A. E., Weroha, S. J., Glaser, G. E., Kumar, A., Langstraat, C. L., Solseth, M. L., Deeds, M. C., Knutson, K. L. and Cannon, M. J.  Th17-inducing autologous dendritic cell vaccination promotes antigen-specific cellular and humoral immunity in ovarian cancer patients.  Nature Communications.  2020; 11(1).  doi: 10.1038/s41467-020-18962-z